Convergent Validity of New Disease Assessment Instruments in Systemic Lupus Erythematosus in Relation to Sledai-2K

被引:0
|
作者
Collins, Christopher [1 ]
Chatham, W. Winn [2 ]
Busch, Howard [3 ]
Gaylis, Norman B. [4 ]
Hautamaki, Emily [5 ]
Narayanan, Siva [6 ]
机构
[1] MedStar Washington Hosp Ctr, Washington, DC USA
[2] Univ Alabama Birmingham, Med Clin Immunol & Rheumatol, Birmingham, AL USA
[3] Sci & Res Inst, Jupiter, FL USA
[4] Arthrit & Rheumat Dis Specialties, Aventura, FL USA
[5] Ipsos Healthcare, Washington, DC USA
[6] Ipsos Healthcare, Global Evidence Value & Access, Washington, DC USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
771
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Early Improvement in SLEDAI-2K Responder Index-50 Predicts SRI-4 Response in a Randomized Placebo-Controlled Trial of Ustekinumab (UST) in Systemic Lupus Erythematosus
    Touma, Zahi
    Gladman, Dafna
    Rose, Shawn
    Fei, Kaiyin
    Gregan, Yun
    Gordon, Robert
    Lo, Kim Hung
    Urowitz, Murray
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [42] Summarizing disease features over time:: II.: Variability measures of SLEDAI-2K
    Ibanez, Dominique
    Gladman, Dafna
    Urowitz, Murray
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (02) : 336 - 340
  • [43] Validity of the Disease Repercussion Profile in patients with systemic lupus erythematosus
    Sharpe, L
    Denton, F
    Schrieber, L
    [J]. LUPUS, 2004, 13 (06) : 428 - 435
  • [44] The validity of the inclusion of "lupus headache" in the systemic lupus erythematosus disease activity index
    Davey, Richard
    Bamford, John
    Emery, Paul
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (08): : 2812 - 2813
  • [45] PREVALENCE OF HYPOVITAMINOSIS D IN ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOUS AND RELATIONSHIP WITH SLEDAI-2K COMPONENTS IN PATIENTS ATTENDED IN TWO RHEUMATOLOGY SERVICES, BOGOTA 2016
    Mejia, M. C.
    Guzman, R. A.
    Teheran, A. A.
    Pineros, L. G.
    Cadavid, V.
    Barrera, M. C.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S602 - S602
  • [46] Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects
    Yee, Chee-Seng
    McElhone, Kathleen
    Teh, Lee-Suan
    Gordon, Caroline
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2009, 23 (04): : 457 - 467
  • [47] Imaging Assessment of Cardiovascular Disease in Systemic Lupus Erythematosus
    Croca, Sara C.
    Rahman, Anisur
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [48] Efficacy of Anifrolumab in Systemic Lupus Erythematosus by Overall and Organ-Specific SLEDAI-2K Improvements: Results from the Randomized, Placebo-Controlled Phase 3 Long-Term Extension Study
    Furie, Richard A.
    Kalunian, Kenneth
    Morand, Eric
    Bruce, Ian
    Manzi, Susan
    Tanaka, Yoshiya
    Withrop, Kevin
    Hupka, Ihor
    Hultquist, Micki
    Tummala, Raj
    Abreu, Gabriel
    Lindholm, Catharina
    Al-Mossawi, Hussein
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1184 - 1186
  • [49] SLEDAI-2K Responder Index (SRI)-50: A Reliable Index for Measuring Improvement in Disease Activity
    Touma, Zahi
    Urowitz, Murray
    Fortin, Paul R.
    Landolt-Marticorena, Carolina
    Toloza, Sergio
    Riddell, Claire
    Chandran, Vinod
    Eder, Lihi
    Ghanem, Aqeel
    Ziouzina, Olga
    Taghavi-zadeh, Shahrzad
    Ibanez, Dominique
    Gladman, Dafna
    [J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1171 - 1172
  • [50] PREVALENCE OF HYPOVITAMINOSIS D IN ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOUS AND ITS RELATIONSHIP WITH SLEDAI-2K COMPONENTS IN PATIENTS TREATED IN TWO RHEUMATOLOGY SERVICES, BOGOTA 2017
    Guzman, R. A.
    Pineros, L. G.
    Garcia, J.
    Pombo, L. M.
    Teheran, A. A.
    Mejia, M. C.
    Cadavid, V.
    Bustillo, J.
    Guzman, K.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S16 - S16